A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
Public ClinicalTrials.gov record NCT04628494. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
Study identification
- NCT ID
- NCT04628494
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Genmab
- Industry
- Enrollment
- 484 participants
Conditions and interventions
Conditions
Interventions
- Epcoritamab Biological
- Investigator's Choice Chemotherapy Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 12, 2021
- Primary completion
- Oct 12, 2025
- Completion
- Mar 31, 2028
- Last update posted
- May 4, 2026
2021 – 2028
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Indiana Blood and Marrow Transplantation | Indianapolis | Indiana | 46237 | — |
| Community Health Network Cancer Center North | Indianapolis | Indiana | 46250 | — |
| University of Kentucky Markey Cancer Center | Lexington | Kentucky | 40536 | — |
| Henry Ford Health System | Jackson | Michigan | 49201 | — |
| MMCORC Attn Delaney Anderson | Saint Louis Park | Minnesota | 55416 | — |
| MD Anderson Cancer Center at Cooper | Camden | New Jersey | 08103 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27157 | — |
| The Christ Hospital Cancer Center | Cincinnati | Ohio | 45229 | — |
| TriHealth Cancer Institute- Good Samaritan Hospital | Cincinnati | Ohio | 45247 | — |
| Brooke Army Medical Center | Fort Sam Houston | Texas | 78234 | — |
| Community Cancer Trials of Utah | Ogden | Utah | 84405 | — |
| LDS Hospital | Salt Lake City | Utah | 84143 | — |
| Virginia Commonwealth University (VCU) Massey Cancer Center | Richmond | Virginia | 23298 | — |
| North Star Lodge Cancer Center | Yakima | Washington | 98902 | — |
| Waukesha Memorial Hospital | Waukesha | Wisconsin | 53188 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 171 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04628494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2026 · Synced May 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04628494 live on ClinicalTrials.gov.